Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Iron deficiency anemia may offer protection against malaria infection

Iron deficiency anemia may offer protection against malaria infection

Chronic granulomatous disease (CGD) research: an interview with Dr. Griffin Rodgers, NIDDK director

Chronic granulomatous disease (CGD) research: an interview with Dr. Griffin Rodgers, NIDDK director

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

What factors affect readmission risk after plastic surgery?

What factors affect readmission risk after plastic surgery?

Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC

Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC

URI professor studies rare hereditary disorder Fanconi anemia in children

URI professor studies rare hereditary disorder Fanconi anemia in children

HCV treatment with sofosbuvir and ribavirin results in sustained virologic response

HCV treatment with sofosbuvir and ribavirin results in sustained virologic response

Implementation of better blood-management plan changes culture at UAB

Implementation of better blood-management plan changes culture at UAB

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences signs definitive agreement to buy Ceregene

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Pre-doctoral students receive International Student Research Fellowships from HHMI

Pre-doctoral students receive International Student Research Fellowships from HHMI

Medicare changes appear to be driving reduced used of dialysis drugs

Medicare changes appear to be driving reduced used of dialysis drugs

ASH announces 12 recipients of its second round of ASH Bridge Grants

ASH announces 12 recipients of its second round of ASH Bridge Grants

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Computer model to improve design of artificial platelets and treat blood disorders

Computer model to improve design of artificial platelets and treat blood disorders

State highlights: Accusations of fraud or abuse in disabled, rehabilitation clinics in N.Y., Mich. and Calif.

State highlights: Accusations of fraud or abuse in disabled, rehabilitation clinics in N.Y., Mich. and Calif.

Research suggests blocking DNA repair complex helps fight therapy-resistant leukemia

Research suggests blocking DNA repair complex helps fight therapy-resistant leukemia

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

Researchers reveal location of human blood stem cells that may improve bone marrow transplants

Researchers reveal location of human blood stem cells that may improve bone marrow transplants

Viropharma announces financial results for second quarter of 2013

Viropharma announces financial results for second quarter of 2013

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.